Raziskovalni peptidi

Retatrutide Research Starter Kit — everything needed to begin retatrutide research in one bundle. Includes: retatrutide 10mg (lyophilized, ≥98% purity per supplier batch spec), bacteriostatic water 5ml, 2 × 3ml syringes, 5 × 1ml insulin syringes. Kit saves EUR 27.47 vs buying components separately. Research use only.

Tirzepatide Research Starter Kit — complete bundle for tirzepatide research. Includes: tirzepatide 10mg (lyophilized, ≥98% purity per supplier batch spec), bacteriostatic water 5ml, 2 × 3ml syringes, 5 × 1ml insulin syringes. Kit saves EUR 26.97 vs buying components separately. For laboratory research use only — not for human consumption.

Research-grade Liraglutide. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.

Research-grade Retatrutide + Cagrilintide Blend — 5 mg Retatrutide + 5 mg Cagrilintide (10 mg total) per vial. ≥ 98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.

Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies. Triple hormone receptor agonism (GIP/GLP-1/Glucagon) Metabolic pathway modulation research Energy homeostasis and body composition studies For research purposes only.

Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist peptide studied for metabolic and insulinotropic signalling pathways in vitro research. Features a C-20 fatty diacid moiety enabling extended pharmacokinetic profile. Shipped to a ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Key research areas: Dual incretin receptor signaling and glucose-dependent insulin secretion Insulin-sensitivity and metabolic-homeostasis pathways studied in research models Body-weight and energy-balance signalling studied in research models For research purposes only. Not for human consumption.

Semaglutide is a long-acting GLP-1 receptor agonist peptide analogue (CAS 910463-68-2), supplied by CertaPeptides as lyophilized powder for laboratory research use only (≥98% supplier batch specification; selected lots independently tested, 99.3% avg across published reports). It is widely used as a long-acting reference GLP-1R agonist in incretin receptor-pharmacology and preclinical metabolic-model research. For laboratory research use only. Not for human consumption.